Can the liver X receptor work its magic in skeletal muscle too? A. Krook Commentary 10 March 2006 Pages: 819 - 821
The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group On behalf of EDEGN. G. ForouhiN. J. Wareham Article 09 March 2006 Pages: 822 - 827
Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis M. J. KnolJ. W. R. TwiskF. Pouwer Article 07 March 2006 Pages: 837 - 845
Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus E. BonoraG. CorraoJ. B. Meigs Article 11 March 2006 Pages: 846 - 854
Better cognitive performance following a low-glycaemic-index compared with a high-glycaemic-index carbohydrate meal in adults with type 2 diabetes Y. PapanikolaouH. PalmerC. E. Greenwood Article 01 March 2006 Pages: 855 - 862
Bone mineral density and its determinants in diabetes: the Fremantle Diabetes Study V. RakicW. A. DavisT. M. E. Davis Article 04 March 2006 Pages: 863 - 871
Blood glucose lowering by means of lifestyle intervention has different effects on adipokines as compared with insulin treatment in subjects with type 2 diabetes A.-M. AasI. SeljeflotK. I. Birkeland Article 23 March 2006 Pages: 872 - 880
Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk The European Nicotinamide Diabetes Intervention Trial (ENDIT) GroupP. J. BingleyE. A. M. Gale Article 03 March 2006 Pages: 881 - 890
Efficacy and safety of preprandial human insulin inhalation powder versus injectable insulin in patients with type 1 diabetes S. GargJ. RosenstockD. B. Muchmore Article 28 February 2006 Pages: 891 - 899
Space–time clustering analyses of type 1 diabetes among 0- to 29-year-olds in Yorkshire, UK R. J. Q. McNallyR. G. FeltbowerP. A. McKinney Short Communication 24 March 2006 Pages: 900 - 904
How much might achievement of diabetes prevention behaviour goals reduce the incidence of diabetes if implemented at the population level? R. K. SimmonsA.-H. HardingS. J. Griffin Article 01 March 2006 Pages: 905 - 911
High-fibre, low-fat diet predicts long-term weight loss and decreased type 2 diabetes risk: the Finnish Diabetes Prevention Study J. LindströmM. PeltonenJ. Tuomilehto Article 16 March 2006 Pages: 912 - 920
Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984–2002 C. HerderJ. BaumertH. Kolb Article 11 March 2006 Pages: 921 - 929
Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin J. M. M. EvansS. A. OgstonA. D. Morris Article 09 March 2006 Pages: 930 - 936
Effect of age on the association of non-high-density-lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the Casale Monferrato study G. BrunoF. MerlettiP. Cavallo-Perin Article 09 March 2006 Pages: 937 - 944
Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria K. RappJ. SchroederS. K. Weiland Article 24 March 2006 Pages: 945 - 952
Alternative splicing of G6PC2, the gene coding for the islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP), results in differential expression in human thymus and spleen compared with pancreas R. S. DograP. VaidyanathanA. Pugliese Short Communication 07 March 2006 Pages: 953 - 957
Lack of association of type 1 diabetes with the IL4R gene H. Q. QuM. C. TessierC. Polychronakos Short Communication 15 March 2006 Pages: 958 - 961
Expression of the gene for a membrane-bound fatty acid receptor in the pancreas and islet cell tumours in humans: evidence for GPR40 expression in pancreatic beta cells and implications for insulin secretion T. TomitaH. MasuzakiK. Nakao Article 09 March 2006 Pages: 962 - 968
Upregulation of rat Ccnd1 gene by exendin-4 in pancreatic beta cell line INS-1: interaction of early growth response-1 with cis-regulatory element J.-H. KangM.-J. KimY.-H. Jo Article 18 March 2006 Pages: 969 - 979
Growth arrest- and DNA-damage-inducible 45β gene inhibits c-Jun N-terminal kinase and extracellular signal-regulated kinase and decreases IL-1β-induced apoptosis in insulin-producing INS-1E cells C. M. LarsenM. G. DøssingT. Mandrup-Poulsen Article 10 March 2006 Pages: 980 - 989
Activation of liver X receptors promotes lipid accumulation but does not alter insulin action in human skeletal muscle cells D. CozzoneC. DebardH. Vidal Article 16 February 2006 Pages: 990 - 999
Discordant gene expression in skeletal muscle and adipose tissue of patients with type 2 diabetes: effect of interleukin-6 infusion A. L. CareyE. Wolsk PetersenM. A. Febbraio Article 15 March 2006 Pages: 1000 - 1007
Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in type 2 diabetes: the role of Niemann–Pick C1-like 1, ATP-binding cassette, transporters G5 and G8, and of microsomal triglyceride transfer protein S. LallyC. Y. TanG. H. Tomkin Article 04 March 2006 Pages: 1008 - 1016
Amino acids require glucose to enhance, through phosphoinositide-dependent protein kinase 1, the insulin-activated protein kinase B cascade in insulin-resistant rat adipocytes C. HinaultI. Mothe-SatneyE. Van Obberghen Article 21 March 2006 Pages: 1017 - 1026
High glucose alters the expression of genes involved in proliferation and cell-fate specification of embryonic neural stem cells J. FuS. S. W. TayS. T. Dheen Article 01 March 2006 Pages: 1027 - 1038
Myofibroblast progenitor cells are increased in number in patients with type 1 diabetes and express less bone morphogenetic protein 6: a novel clue to adverse tissue remodelling? T. Q. NguyenH. ChonR. Goldschmeding Article 18 March 2006 Pages: 1039 - 1048
Insulin activates hypoxia-inducible factor-1α in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways: impairment in insulin resistance owing to defects in insulin signalling G. DoronzoI. RussoM. Trovati Article 28 February 2006 Pages: 1049 - 1063
The insulin sensitiser pioglitazone does not influence skin microcirculatory function in patients with type 2 diabetes treated with insulin J. E. TookeL. M. ElstonA. C. Shore Article 01 March 2006 Pages: 1064 - 1070
Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus E. J. DunnH. PhilippouP. J. Grant Article 16 March 2006 Pages: 1071 - 1080
Remote neurotrophic support of epidermal nerve fibres in experimental diabetes C. TothV. BrusseeD. W. Zochodne Article 10 March 2006 Pages: 1081 - 1088
Effect of R-(+)-α-lipoic acid on experimental diabetic retinopathy J. LinA. BierhausH.-P. Hammes Article 07 March 2006 Pages: 1089 - 1096
Cardiomyocyte dysfunction in insulin-resistant rats: a female advantage M. L. SchwankeK. DuttaA. J. Davidoff Article 16 March 2006 Pages: 1097 - 1105
Phenotypic heterogeneity between different mutations of MODY subtypes and within MODY pedigrees S. S. FajansG. I. Bell Research Letter 25 February 2006 Pages: 1106 - 1108
Increased clonogenic potential of circulating endothelial progenitor cells in patients with type 1 diabetes and proliferative retinopathy V. AsnaghiR. LattanzioG. Zerbini Research Letter 07 March 2006 Pages: 1109 - 1111
Human resistin promotes macrophage lipid accumulation C. RaeA. Graham Research Letter 11 March 2006 Pages: 1112 - 1114
Proteoglycans can mediate renal lipoprotein retention L. R. Tannock Research Letter 11 March 2006 Pages: 1115 - 1116
Glucose metabolism is altered in the adequately-nourished grand-offspring (F3 generation) of rats malnourished during gestation and perinatal life D. C. BenyshekC. S. JohnstonJ. F. Martin Research Letter 24 March 2006 Pages: 1117 - 1119
Endogenous beta-galactosidase expression in murine pancreatic islets A. InadaC. NienaberS. Bonner-Weir Research Letter 16 March 2006 Pages: 1120 - 1122
Transgenic overproduction of murine 60 kDa heat shock protein in the liver does not prevent type I diabetes in NOD mice S. LüthA. W. LohseJ. Herkel Research Letter 18 March 2006 Pages: 1123 - 1124
To: Scholtz HE, Pretorius SG, Wessels DH, Becker RHA (2005) Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique. Diabetologia 48:1988–1995 J. H. DeVries Letter 07 March 2006 Pages: 1125 - 1126
To: Holstein A, Stumvoll M (2005) Contraindications can damage your health—is metformin a case in point? Diabetologia 48:2454–2459 R. C. W. MaC. C. ChowC. S. Cockram Letter 25 March 2006 Pages: 1127 - 1128
Comment on: Gale EAM (2005) Spring harvest? Reflections on the rise of type 1 diabetes. Diabetologia 48:2245–2250; and Walker M, Mari A, Jayapaul MK et al (2005) Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects. Diabetologia 48:2470–2476 B. J. Boucher Letter 24 March 2006 Pages: 1129 - 1130
